Related Experiment Video

Updated: Aug 22, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Pharmacogenomics: road to anticancer therapeutics nirvana?

Apurva A Desai1, Federico Innocenti, Mark J Ratain

  • 1Department of Medicine, The University of Chicago, Chicago, IL, USA.

Oncogene
|October 7, 2003
PubMed

Insights

Pharmacogenomics helps predict patient responses to cancer drugs by studying genetic variations. This approach aims to personalize treatments, improving efficacy and reducing toxicity for better patient outcomes.

Area of Science:

  • Oncology
  • Pharmacogenomics
  • Genetics

Background:

  • Interindividual variability in anticancer drug response and toxicity is a significant clinical challenge.
  • Unpredictable drug responses are especially dangerous for anticancer agents with narrow therapeutic indices.
  • Pharmacogenomics seeks to understand the genetic basis of these differences to enable individualized cancer treatments.

Purpose of the Study:

  • To review the role of pharmacogenomics in anticancer therapeutics.
  • To highlight how genetic variants influence the efficacy and toxicity of cancer treatments.
  • To exemplify the impact of pharmacogenomics using specific gene variants.

Main Methods:

  • Review of existing literature on pharmacogenomics in oncology.
  • Analysis of genetic polymorphisms in drug-metabolizing enzymes, DNA repair genes, and drug targets.
  • Focus on specific examples including UGT1A1, TS, and EGFR genetic variants.

Main Results:

  • Genetic polymorphisms in key genes demonstrably affect anticancer drug toxicity and efficacy.
  • Variants in UGT1A1, TS, and EGFR are shown to influence treatment outcomes.
  • Pharmacogenomic data provides a basis for predicting and managing interindividual drug responses.

Conclusions:

  • Pharmacogenomics holds significant potential for optimizing anticancer therapy.
  • Understanding genetic variations can lead to more individualized and effective cancer treatment strategies.
  • Personalized medicine approaches guided by pharmacogenomics can improve patient safety and treatment success in oncology.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Related Concept Videos

Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...